Stock MNMD MIND MEDICINE (MINDMED) INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Mind Medicine (MindMed) Inc.

Equities

MNMD

CA60255C8850

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-05 pm EDT 		5-day change 1st Jan Change
7.08 USD -0.84% Intraday chart for Mind Medicine (MindMed) Inc. -1.80% +93.44%
Jul. 01 Mind Medicine Inc.(NasdaqGS:MNMD) added to Russell Small Cap Completeness Index CI
Jul. 01 Mind Medicine Inc.(NasdaqGS:MNMD) added to Russell 2000 Index CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
MindMed to be included in Russell 2000 and Russell 3000 Indexes
AQ
Mind Medicine Inc.(NasdaqGS:MNMD) added to Russell Small Cap Completeness Index
CI
Mind Medicine Inc.(NasdaqGS:MNMD) added to Russell 2000 Index
CI
Mind Medicine Inc.(NasdaqGS:MNMD) added to Russell 3000E Index
CI
Mind Medicine Inc.(NasdaqGS:MNMD) added to Russell 3000 Growth Index
CI
Mind Medicine Inc.(NasdaqGS:MNMD) added to Russell 3000E Growth Index
CI
Mind Medicine Inc.(NasdaqGS:MNMD) added to Russell 2000 Growth Index
CI
Mind Medicine Inc.(NasdaqGS:MNMD) added to Russell 2000 Dynamic Index
CI
Mind Medicine Inc.(NasdaqGS:MNMD) dropped from Russell Microcap Value Index
CI
Mind Medicine Inc.(NasdaqGS:MNMD) added to Russell 2500 Growth Index
CI
Mind Medicine Inc.(NasdaqGS:MNMD) added to Russell Small Cap Comp Growth Index
CI
Mind Medicine Inc.(NasdaqGS:MNMD) added to Russell 2500 Index
CI
Mind Medicine Inc.(NasdaqGS:MNMD) added to Russell 3000 Index
CI
Mind Medicine Inc.(NasdaqGS:MNMD) dropped from Russell 3000E Value Index
CI
Mind Medicine to Join Russell 2000, 3000 Indexes
MT
MindMed to be Included in Russell 2000® and Russell 3000® Indexes
BU
MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
AQ
Mind Medicine Inc.(NasdaqGS:MNMD) added to S&P Pharmaceuticals Select Industry Index
CI
MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
BU
MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MNMD Stock
  4. News Mind Medicine (MindMed) Inc.